JW Therapeutics to jump to public markets

Aug 18, 2020 • Robert Lavine

The immuno-oncology company – co-founded by Juno Therapeutics, a spinout of several institutions – is reportedly seeking $250m to $300m in a Hong Kong offering.

JW Therapeutics, the China-based cancer therapy developer launched by biopharmaceutical companies Juno Therapeutics and WuXi AppTec has filed for an initial public offering on the Hong Kong Stock Exchange, Caixin Global reported today.
Earlier reports suggested the company is targeting $200m to $300m in the offering, and the sponsors for it are Goldman Sachs and UBS.
Founded in 2016 as a joint venture between Juno Therapeutics and WuXi AppTec, JW is working on immuno-oncology drugs that utilise engineered…

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

2024 marks flurry of university spinout fund launches

University venture funds are becoming an increasingly important tool for universities to support their ecosystems — here are the new ones launched in 2024.

UK universities ready to pick up the pace of commercialisation in 2025

The UK stands to benefit from the work of the past 12 months to push more university research-led innovation into the marketplace.

Databricks cofounder launches $150m spinout fund with UC Berkeley focus

The investment fund will mostly back founders from the US university.

Events

Webinar: Designing a winning CVC platform – Engagement, venture development, operations

Jan 15, 2025
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

Jan 28 -
Jan 29, 2025
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

Mar 17 -
Mar 18, 2025
Palo Alto, CA (USA)

Find out more All events

Events

GCVI Summit 2025

Mar 18 -
Mar 20, 2025
Monterey, CA (USA)

Find out more All events

Events

GCV Institute: CVC Investment Programs

Apr 8 -
Apr 10, 2025
Online

Find out more All events

Events

GCV Institute: Landing the Value of Corporate Venturing

May 1 -
May 6, 2025
Online

Find out more All events

Events

GCV Symposium 2025

Jun 17 -
Jun 19, 2025
London (UK)

Find out more All events

About us

Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.